Why Ginkgo Bioworks Stock Is Sliding Wednesday Morning


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower by 8.63% to $2.44 Wednesday morning. The company during Tuesday's after-hours session announced a public offering of Class A common stock.

What Else?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Ginkgo intends to use the net proceeds from the offering to offset the cash used to finance the acquisition of certain assets and liabilities of Bayer CropScience LP and for other general corporate purposes.

In connection with this offering, Ginkgo has also granted the underwriter a 30-day option to purchase up to an additional $15 million of shares of Class A common stock.

See Also: Here's The Level Amazon Must Hold For This Bullish Pattern To Become Dominant

According to data from Benzinga Pro, DNA has a 52-week high of $14.20 and a 52-week low of $2.09.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Penny StocksMoversTrading Ideaswhy it's moving